Majority of studies were conducted in subjects having metabolic or endocrinologic abnormalities such as T2DM, insulin resistance, obesity, metabolic syndrome (MetS) or PCOS [21,42,44,45,46,48], but some studies investigated antidepressant effects of insulin in subjects without metabolic abnormalities [43,47,49,51]. This evidence concerns the gene INS and metabolic syndrome.